WHOLE BLOOD, SERUM AND PLASMA CHEMISTRY:H-N
|
TYPICAL REFERENCE INTERVALS |
||||
|
Haptoglobin |
Serum |
60-270 mg/dL |
0.01 |
0.6-2.7 g/L |
|
Hemoglobin |
Serum or Plasma Qualitative Quantitative Whole Blood Female Male |
Negative 0.5-5.0 mg/dL 12.0-16.0 g/dL 13.5-18.0 g/dL |
--- 10 10 |
Negative 5-50 mg/L 120-160 g/L 135-180 g/L |
|
a -Hydoxybutyrate dehydronase |
Serum |
140-350 U/mL |
1 |
140-350 kU/L |
|
17- Hydroxycorticosteroids |
Plasma Male Female After 24 USP Units of ACTH I.M. |
7-19 Fg/dL9-21 Fg/dL
35-55 Fg/dL |
25.591 |
193-524 nmol/L 248-579 nmol/L
966-1517 nmol/L |
|
Immunoglobulins: IgG IgA IgM IgD IgE |
Serum |
800-1801 mg/dL 113-563 mg/dL 54-222 mg/dL 0.5-3.0 mg/dL 0.01-0.04 mg/dL |
0.01
10 |
8.0-18.0 g/L 1.1-5.6 g/L 0.5-2.2 g/L 5.0-30.0 mg/L 0.1-0.4 mg/L |
|
Insulin |
Plasma Bioassay Radioumunoassay |
11-240 FIU/mL4-24 FIU/mL |
7.175++ |
79-1722 pmol/L 29-172 pmol/L |
|
Insulin tolerance (0.1 unit/kg) |
Serum Fasting 30 min 90 min |
Glucoseof 70-110 mg/dL Fall to 50% of fasting level Fasting level |
0.05551 0.01 |
Glucose of 3.9-6.1 mmol/L Fall to 0.5 of fasting level Fasting level |
|
Iron, total |
Serum |
60-150 Fg/dL |
0.1719 |
10.7-26.9 mmol/L |
|
Iron-binding capacity |
Serum |
250-400 Fg/dL |
0.1719 |
44.8-71.6 mmol/L |
|
Iron Saturation |
Serum |
20-55% |
0.01 |
Fraction of total iron-biding capacity : 0.20-0.55 |
|
Isocitric dehydrogenase |
Serum |
50-240 units/mL at 25 EC(Wolfson-Williams Ashman units) |
0.0166 |
0.83-4.18 U/L at 25 EC |
|
Ketone bodies |
Serum |
Nagative |
--- |
Negative |
|
17- Ketosteroids |
Plasma |
25-125 Fg/dL |
34.67 W |
866-4334 nmol/L |
|
Lactic acid (as lactate) |
Whole Blood Venous Arterial |
5-20 mg/dL 3-7 mg/dL |
0.1110 |
0.6-2.2 mmo/L 0.3-0.8 mmol/L |
|
Lactate Dehydrogenase (LD) |
Serum |
(lactate 6pyruvate) 80-120 units at 30ECpyruvate 6lactate)185-640 units at 30EClactate 6pyruvate) 100-190 U/L at 37EC |
0.48
1 |
38-62 U/L at 30 EC90-310 U/L at 30 EC100-190 U/L at 37 EC |
|
Lactate dehydrogenase isoenzymes LD1 (anode) LD2 LD3 LD4 LD5 (cathode) |
Serum |
17-27% 27-37% 18-25% 3-8% 0-5% |
0.01 |
Fraction of total LD 0.017-0.27 0.27-0.37 0.18-0.25 0.03 -0.08 0.00-0.05 |
|
Lactate Dehydrogenase (heat stable) |
Serum |
30-60% of total |
0.01 |
Fraction of total LD: 0.30-060 |
|
Lactose tolerance |
Serum |
Serum glucose changes similar to glucose tolerance tests |
--- |
Serum glucose changes similar to glucose tolerance test |
|
Lead |
Whole blood |
<50 Fg/dL |
0.04826 |
<2.41 mmol/L |
|
Leucine aminopeptidase (LAP) |
Serum Male Female |
80-200 U/mL (Goldbarg-Rutenberg) 75-185 U/mL (Goldbarg-Rutenberg) |
0.24 |
19.2-48.0 U/L 18.0-44.4 U/L |
|
Lipase |
Serum |
0-1.5 U/mL (Cherry-Crandall) 14-280 mIU/mL |
278 1 |
0-417 U/L 14-280 U/L |
|
Lipids, total Cholesterol Triglycerides Phospholipids Fatty acids (free) Phospholipid phosphorus |
Serum |
400-800 mg/dL 150-250 mg/dL 10-90 mg/dL 150-380 mg/dL 9.0-15.0 mmol/L 8.0-11.0 mg/dL |
0.01 0.02586 0.01129** 0.01 1 0.3229 |
4.00-8.00 g/L 3.88-6.47 mmol/L 0.11-2.15 mmol/L 1.50-3.80 g/L 9.0-15.0 mmol/L 2.58-3.55 mmol/L |
|
Lithium therapeutic interval |
Serum |
Negative 0.5-1.4 mEq/L |
--- 1 |
Negative 0.5-1.4 mmol/L |
|
Long-acting thyroid-stimulating hormone (LATS) |
Serum |
None detected |
--- |
None detected |
|
Luteinizing hormone(LH) |
Serum Male Female |
6-30 mIU/mL Midcycle peak: 3 times baseline value Premenopausal <30 mIU/mL Postmenopausal>35 mIU/mL |
1 |
6-30 IU/L Midcycle peak: 3 times baseline value Premenopausal <30 IU/L Postmenopausal>35 IU/L |
|
Macrogobulins, total |
Serum |
70-430 mg/dL |
0.01 |
0.7-4.3 g/L |
|
Methemoglobin |
Whole Blood |
<0.24 g/dL <1% of total hemoglobin |
10 0.01 |
<2.4 g/L Fraction of total hemoglobin <0.01 |
|
Mucoprotien |
Serum |
80-200 mg/dL |
0.01 |
0.8-2.0 g/L |
|
Muramidase |
Serum |
4-13 mg/L |
|
4-13 mg/L |
|
Myoglobin |
Serum |
<90 Fg/L |
|
<90 mg/L |
|
Nonprotien nitrogen (NPN) |
Serum or Plasma Whole Blood |
20-35 mg/dL 25-50 mg/dL |
0.7139 |
14.3-25.0 mmol/L 17.8-35.7 mmol/L |
|
5'- Nucleotidase |
Serum |
0-1.6 units at 37 EC |
1 |
0-1.6 units at 37 EC |